Evidence map›Paper›PMID 42038408›Full record

ArticleNAR genomics and bioinformatics2026

CNV-Hub: an integrated web-based platform for CNV classification and interpretation using multi-algorithm consensus.

Vignesh Guru Victor Pillay, Anne-Laure Mosca, Davide Callegarin, Nathalie Marle, Tristan Moro, Mélodie Opale, Nada Maaziz, Gregory Egea, Muriel Payet, Clémence Ragon and 5 more

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vignesh Guru Victor PillayDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.ORCID https://orcid.org/0009-0002-9561-3645
Anne-Laure MoscaDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Davide CallegarinDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Nathalie MarleDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Tristan MoroDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Mélodie OpaleDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Nada MaazizDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Gregory EgeaLaboratoire de Génétique, GenBio-Inovie, Clermont-Ferrand, 63000, France.
Muriel PayetDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Clémence RagonDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Julia MosnierDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Alison BouzenardDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.
Ludwig Serge AhoDepartment of Epidemiology, Dijon University Hospital, Dijon, 21000, France.
Laurence FaivreDepartment of Clinical Genetics, Dijon University Hospital, Dijon, 21000, France.
Patrick CallierDepartment of Chromosomal and Molecular Genetics, Dijon University Hospital, Dijon, 21000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copy number variations (CNVs) are genomic alterations that can cause rare genetic diseases. Their interpretation requires consulting multiple databases and following classification guidelines, such as those from the American College of Medical Genetics (ACMG) and the Clinical Genome Resource (ClinGen). In France, the Achro-Puce working group has also established recommendations to support CNV interpretation. Despite these resources, CNV analysis remains time-consuming, as it requires reviewing gene content, regulatory elements, and associated syndromes. To address this challenge, we developed CNV-Hub, a web-based platform that streamlines CNV classification and interpretation. CNV-Hub integrates five algorithms: two based on ACMG recommendations (AnnotSV, ClassifyCNV), two using machine learning (X-CNV, ISV), and one specifically developed according to French guidelines. In addition to automated pathogenicity predictions, CNV-Hub provides annotations for each CNV, including gene dosage sensitivity scores (pHaplo, pTriplo), syndrome associations, and direct links to databases such as OMIM and PubMed. The platform's user-friendly interface enables rapid, evidence-based CNV evaluation. By incorporating machine learning among its classification algorithms, CNV-Hub improves the interpretation of uncertain variants by integrating additional parameters. This tool reduces the time required for CNV analysis while maintaining accuracy and reliability, representing a significant advance in molecular cytogenetics and supporting geneticists in clinical decision-making.

Indexed as

AlgorithmsDNA Copy Number VariationsSoftwareClassification AlgorithmsDatabases, GeneticHumansInternetMachine Learning

Identifiers

PMID42038408
PMCPMC13103734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.